Reply to "Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management"

Affiliations

• ¹ Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Division of Psychiatry, University College London, London, UK; The LonDownS Consortium, London, UK. Electronic address: carla.startin.09@ucl.ac.uk.
• ² Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Division of Psychiatry, University College London, London, UK; The LonDownS Consortium, London, UK.
• ³ Division of Psychiatry, University College London, London, UK; The LonDownS Consortium, London, UK.
• ⁴ The LonDownS Consortium, London, UK; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK; Division of Life Science, Hong Kong University of Science and Technology, Hong Kong SAR, People's Republic of China.
• ⁵ The LonDownS Consortium, London, UK; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK; Reta Lila Weston Institute, Institute of Neurology, University College London, London, UK.